Pure Global

“Vircell” VARICELLA-ZOSTER VIRCLIA IgG MONOTEST - Taiwan Registration 8af556fa1807c2889c2c2eb26a973fc4

Access comprehensive regulatory information for “Vircell” VARICELLA-ZOSTER VIRCLIA IgG MONOTEST in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 8af556fa1807c2889c2c2eb26a973fc4 and manufactured by VIRCELL, S.L. The authorized representative in Taiwan is Abbott Rapid Diagnostics Health Corp..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
8af556fa1807c2889c2c2eb26a973fc4
Registration Details
Taiwan FDA Registration: 8af556fa1807c2889c2c2eb26a973fc4
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

“Vircell” VARICELLA-ZOSTER VIRCLIA IgG MONOTEST
TW: “凡賽爾”水痘帶狀皰疹病毒化學冷光免疫分析IgG試劑組
Risk Class 2
MD

Registration Details

8af556fa1807c2889c2c2eb26a973fc4

Ministry of Health Medical Device Import No. 031450

DHA05603145007

Company Information

Spain

Product Details

This product is an indirect chemiluminescent immunoassay (CLIA) reagent with ThunderBolt Analyzer. Detection of IgG antibodies against varicella zoster virus in human plasma.

C Immunology and microbiology devices

C3900 Varicella zoster virus serum reagent

Imported from abroad

Dates and Status

Sep 05, 2018

Sep 05, 2023